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Although innate lymphoid cells (ILCs) functionally analogous to T helper type 1 (Th1), Th2, and Th17 cells are well
characterized, an ILC subset strictly equivalent to IL-10–secreting regulatory T cells has only recently been proposed. Here, we
report the absence of an intestinal regulatory ILC population distinct from group 1 ILCs (ILC1s), ILC2s, and ILC3s in (1) mice
bred in our animal facility; (2) mice from The Jackson Laboratory, Taconic Biosciences, and Charles River Laboratories; and (3)
mice subjected to intestinal inflammation. Instead, a low percentage of intestinal ILC2s produced IL-10 at steady state. A screen
for putative IL-10 elicitors revealed that IL-2, IL-4, IL-27, IL-10, and neuromedin U (NMU) increased IL-10 production in
activated intestinal ILC2s, while TL1A suppressed IL-10 production. Secreted IL-10 further induced IL-10 production in ILC2s
through a positive feedback loop. In summary, ILC2s provide an inducible source of IL-10 in the gastrointestinal tract, whereas
ILCregs are not a generalizable immune cell population in mice.

Introduction
Innate lymphoid cells (ILCs) are a family of cytokine-activated,
cytokine-secreting lymphocytes that reside in barrier tissues
and participate in maintaining mucosal homeostasis and host
defense against infection (Branzk et al., 2018; Sonnenberg and
Artis, 2015). ILCs functionally analogous to polarized CD4+ T cell
subsets are well characterized: group 1 ILC (ILC1) produce IFNγ
and are analogous to T helper (Th) type 1 (Th1) cells; ILC2 produce IL-5, IL-9, and IL-13 and are analogous to Th2 cells; and
ILC3 produce IL-17 and IL-22 and are analogous to Th17 cells
(Eberl et al., 2015; Vivier et al., 2018). ILCs acquire effector
functions during their development and are thus able to rapidly
secrete cytokines upon encountering activating signals.
CD4+ regulatory T cells (T reg cells) are a major source of the
anti-inflammatory cytokine IL-10. IL-10 is required for maintaining intestinal homeostasis, as demonstrated by Il10-deficient
mice, which on susceptible genetic backgrounds develop spontaneous colitis due to dysregulated activation of CX3CR1+ macrophages and Th1 cells (Berg et al., 1996; Davidson et al., 1996;
Kühn et al., 1993). The functional parallels between polarized
CD4+ T cells and ILC subsets have raised the question of whether
ILC analogous to T reg cells are present in the gut. Recently, a
novel IL-10–secreting ILC fitting this role, termed the regulatory
ILC (ILCreg), was reported in the intestine (Wang et al., 2017).
ILCregs were a distinct population from ILC1s, ILC2s, and ILC3s
and were functionally analogous to T reg cells based on their

ability to suppress cytokine production in intestinal ILC1s and
ILC3s via IL-10. ILCregs were most abundant in small intestine
lamina propria, and these cells expanded in number during
multiple models of intestinal inflammation. However, evidence of other IL-10–producing ILCs in barrier tissues has
emerged with reports that activated lung ILC2s can produce
IL-10 after chronic treatment with papain (Miyamoto et al.,
2019; Seehus et al., 2017). These findings raise the possibility
that ILC2s may be major IL-10–producing ILCs in the gut,
particularly in the context of type 2 immune activation induced by protozoa and parasitic helminths. The relative contributions of IL-10 by ILCregs and ILC2s in the gastrointestinal
tract remain undefined.
Here, we used a cytokine reporter mouse to identify innate
lymphocytes that produce IL-10 in the intestine. We show that
mice bred in our facility lacked ILCregs based on IL-10 reporter
expression. Confirming this finding, mice bred in our facility or
purchased from laboratory mouse vendors (The Jackson Laboratory [JAX], Taconic Biosciences, and Charles River Laboratories) showed no evidence of ILCregs based on staining for ILCs
distinct from ILC1s, ILC2s, and ILC3s. Additionally, ILCregs were
not observed during dextran sodium sulfate (DSS)–induced colitis or Citrobacter rodentium infection, two models of intestinal
inflammation. Instead, within the lineage-negative lymphocyte
compartment, a small percentage of ILC2s produced IL-10. Using
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Figure 1. No evidence for IL-10–producing Lin−CD127+Thy1+ cells in naive small and large intestine. (A and B) Representative FACS plots showing IL10–eGFP expression in small intestine (SI) and large intestine (LI) lamina propria (LP) CD45+ lymphocyte-sized Lin−CD45+CD127+ cells (A) and CD4+ T cells (B).
(C) Frequencies of eGFP+ cells among lymphocyte-sized Lin−CD45+CD127+Thy1+ cells and CD4+ T cells in small intestine and large intestine lamina propria in
multiple mice (n = 4). (D) Modified gating scheme to account for all cell lineages that expressed eGFP within the lymphocyte-based FSC/SSC gate. (E) Modified
gating scheme to include cells with an expanded FSC/SSC profile. Below, the FSC/SSC profile of CD3e+ cells is shown as a reference for where lymphocytes lie
in the plot. Bars indicate means ± SD. Data are representative of two independent experiments.

Results and discussion

lymphocyte-based forward scatter (FSC)/side scatter (SSC) gate.
The majority of eGFP+ cells were T cells, with non-T cell GFP+
events either being CD11b+CD11c+ or CD11b−CD11c−B220− cells
that lacked Thy1 (Fig. 1 D). A separate gating scheme with an
expanded FSC/SSC gate that included larger and more granular
cells, such as monocytes, also did not reveal eGFP+ ILCregs (Fig. 1
E). Thus, naive mice bred in our facility lacked an intestinal cell
population that corresponded to ILCregs based on IL-10 reporter
expression.

No evidence for IL-10–eGFP+ expression in Lin−CD127+Thy1+
cells from naive small and large intestine
ILCregs were previously described as lineage marker-negative
(Lin)−CD127+eGFP+ cells in Il10eGFP/+ (B6.129S6-Il10tm1Flv/J, also
known as IL-10–eGFP) reporter mice (Wang et al., 2017). These
cells were reported to express Thy1 but lacked markers that
define ILC1s (NKp46, NK1.1, and T-bet), ILC2s (KLRG1 and high
amounts of GATA3), and ILC3s (RORγt). To identify innate
lymphoid producers of IL-10, we obtained the same reporter
mice from JAX, bred them with C57BL/6J mice purchased from
JAX, and processed the intestinal lamina propria of their heterozygous progeny. CD45+Lin−CD127+Thy1+ lymphocytes lacked
eGFP in the small and large intestine (Fig. 1, A and C), whereas
CD4+ T cells expressed IL-10 in both tissues (Fig. 1, B and C).
To determine whether the lineage-negative gate excluded
IL-10 producers, an alternate staining strategy was used to account for all cell lineages that expressed eGFP within the live

No evidence for ILCregs based on staining for ILCs distinct
from ILC1s, ILC2s, and ILC3s in small intestines of mice bred at
Washington University School of Medicine (WUSM), mice
purchased from commercial vendors, and mice subjected to
intestinal inflammation
Differences in microbiota have been shown to impact cytokine
production in T cells (Brown et al., 2019). To address the possibility that ILCregs might not produce IL-10 in our animal facility at WUSM due to environmental conditions, an antibody
staining strategy was used in an attempt to identify these cells
without relying on cytokine reporter expression. Small intestine
lamina propria single-cell suspensions were stained with antibodies for cell surface markers and transcription factors to
identify a population of ILCs separate from ILC1s, ILC2s, and
ILC3s. With ILC1 and natural killer (NK) cell markers excluded
by lineage staining, >99% of Lin−CD45+CD127+ small intestine

screens to investigate the signals that induce IL-10 production in
ILC2s, we found that multiple soluble mediators elicited IL-10,
while the TNF superfamily member TL1A strongly inhibited IL-10
production. These data indicate that ILCregs are not broadly observed across laboratory mice, and that instead, ILC2s provide an
inducible source of IL-10 in the gastrointestinal tract.
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Figure 2. No evidence for lineage-negative ILCs distinct from ILC2s and ILC3s in small intestines of mice bred at WUSM and mice purchased from
commercial vendors. (A) Left: Gating strategy to identify lineage-negative events that lacked markers for ILC2s and ILC3s. Right: Frequencies and total
numbers of Lin−CD45+CD127+ cells that were GATA3hi (ILC2s) or RORγt+ (ILC3s) or that lacked markers for both ILC2s and ILC3s (G6) in small intestine lamina
propria of WT mice bred at WUSM (n = 8). (B–D) Frequencies of Lin−CD45+CD127+ cells that lacked ILC2 and ILC3 markers in mice purchased from JAX (n = 8;
B), Taconic Biosciences (n = 8; C), and Charles River Laboratories (n = 8; D). (E) Representative flow cytometry plots showing backgated G6. ILC2s are shown as
a reference for lineage-negative cells. Right, quantified gMFI of lineage staining in G6 and ILC2s (n = 4). (F) T-bet staining in G6 (n = 4). (G) Frequencies of G6,
ILC2s, and ILC3s using a modified lineage staining panel (Modified Lin) in which anti-F4/80 antibodies were added while anti-B220 antibodies were excluded
(n = 4). (H) gMFI of Modified Lin staining in G6 and ILC2s (n = 4). (I) Frequencies of T-bet+ cells within G6 obtained using Modified Lin staining (n = 4). Bars
indicate means ± SD. Data were pooled from two independent experiments (A–D) or are representative of two independent experiments (D–I). ****, P <
0.0001.

lymphocytes were either GATA3hi ILC2s or RORγt+ ILC3s; on
average, <1% of Lin−CD45+CD127+ small intestine lymphocytes
(which excluded ILC1s and NK cells) lacked ILC2 and ILC3
markers (Fig. 2 A). Thus, regardless of IL-10–eGFP expression,
Bando et al.
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mice bred in our facility lacked a population that corresponded
to ILCregs, which was previously reported to be ∼13% of lineagenegative small intestine lamina propria cells based on function
marking alone (Wang et al., 2017).
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IL-10 production is inducible in intestinal ILC2s by IL-2, IL-4,
IL-10, IL-27, and neuromedin U (NMU), and suppressed by TL1A
While IL-10–eGFP expression was absent in Lin−CD127+Thy1+
ILCs, a small population of Lin−CD127+ ILCs that lacked Thy1 was
found to express eGFP in the small intestine, but not large intestine (Fig. 1 A). Lin−CD127+Thy1− cells expressed the ILC2
markers KLRG1 and IL-25R (Fig. 4 A). Consistent with an ILC2
Bando et al.
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phenotype, Lin−CD127+Thy1− cells expressed high amounts of
GATA3, a transcription factor required for ILC2 development
and maintenance (Fig. 4 A; Hoyler et al., 2012). Gating on
Lin−CD45+CD127+KLRG1+ ILC2s that lacked Thy1 enriched for IL10-GFP+ cells (Fig. 4 B).
Activated lung ILC2s were previously shown to produce IL-10
after chronic papain exposure and in response to IL-2
(Miyamoto et al., 2019; Seehus et al., 2017). To identify factors
that could induce IL-10 in intestinal ILC2s, purified eGFPnegative ILC2s from the small intestine lamina propria of
IL-10–eGFP mice were subjected to a screen using candidate
soluble mediators previously reported to impact ILC2 activity,
T reg cell differentiation, and/or T reg cell function (Cardoso
et al., 2017; Duerr et al., 2016; Gao et al., 2009; Josefowicz
et al., 2012; Klose et al., 2017; Li et al., 2018; Lim et al., 2016;
Mchedlidze et al., 2016; Meylan et al., 2014; Moro et al., 2016;
Nussbaum et al., 2013; Ohne et al., 2016; Ricardo-Gonzalez et al.,
2018; Ruiter et al., 2015; Symowski and Voehringer, 2019;
Wallrapp et al., 2017; Yu et al., 2014; Zheng et al., 2016). In this
screen, cells were cultured with the ILC2-activating cytokines
IL-25 and IL-33, together with either IL-7 or TSLP, and a candidate soluble mediator. Percentages of eGFP+ cells were determined by flow cytometry after 2 d. Confirming previous
findings with lung ILC2s (Seehus et al., 2017), IL-2 strongly increased eGFP expression in intestinal ILC2s (Fig. 4 C). eGFP
expression was also induced in ILC2s by IL-10 itself, as well as
IL-27, IL-4, and the neuropeptide NMU. TSLP-treated cells did
not exhibit increased eGFP production compared with IL7–treated cells, and for that reason IL-7 was used instead of
TSLP in subsequent experiments. IL-2, IL-10, IL-27, IL-4, and
NMU were validated as positive regulators of IL-10 using intestinal ILC2s sorted from biological replicates (Fig. 4, D and E). A
separate screen conducted with preactivated ILC2s, which had a
higher baseline of eGFP across all treatments, revealed that the
TNF superfamily member TL1A was a candidate negative regulator of IL-10 production in ILC2s (Fig. 4 F). TL1A was previously
shown to induce IL-5 and IL-13 production by ILC2s (Meylan
et al., 2014; Yu et al., 2014). Consistent with the results from
the screen, TL1A strongly abrogated IL-10 production induced by
IL-2 or IL-4 in vitro (Fig. 4 G).
While a low percentage of eGFP was detected in ILC2s in the
naive mouse small intestine, eGFP was not expressed by NK cells,
ILC1s, or ILC3s (Fig. S1 A). None of the soluble mediators tested on
ILC2s induced IL-10 production in activated ILC3s (Fig. S1, B and
C). Additionally, IL-10 was not induced in ILC1s, NK cells, or ILC3s
during Clostridium difficile infection (Fig. S1 D). Use of Tg Il10
bacterial artificial chromosome in transgene (10BiT) IL-10 reporter mice confirmed that KLRG1+ ILC2s, but not other lineagenegative ILCs, produced IL-10 at steady state (data not shown;
Maynard et al., 2007). Although this area requires further investigation, these results suggest that small intestine ILC1s and
ILC3s are less poised to produce IL-10 than small intestine ILC2s.
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To test whether these results were unique to mice bred in our
facility, WT mice were obtained from the mouse vendors JAX
(C57BL/6J), Taconic Biosciences (C57BL/6N), and Charles River
Laboratories (C57BL/6N). Microbiota associated with these facilities were previously shown to differentially impact abundances of intestinal Th17 cells and CD4+CD8αα+ intraepithelial
lymphocytes (Cervantes-Barragan et al., 2017; Ivanov et al.,
2008). Similar to what was observed in mice bred at WUSM,
ILC2s and ILC3s accounted for >99% of all Lin−CD45+CD127+
small intestinal lamina propria cells in C57BL/6 mice purchased
from each of the three vendor facilities; in each case, <1% of
Lin−CD45+CD127+ flow cytometry events were neither ILC2s nor
ILC3s (Fig. 2, B–D). Thus, in mice obtained from multiple animal
facilities, we found no evidence for ILCs distinct from ILC1s,
ILC2s, and ILC3s in frequencies consistent with what was previously reported for ILCregs. Additionally, the absence of this
population was not due to genetic differences between C57BL/6J
and C57BL/6N substrains.
Next we determined whether the few Lin−CD45+CD127+ flow
cytometry events that lacked ILC2 and ILC3 markers (events
within the flow cytometry gate denoted gate 6 [G6]) had markers
consistent with ILCregs. Backgating revealed that G6 events primarily existed on the edge of the gate that interfaced with
lineage-positive cells, suggesting that the majority of these events
expressed lineage markers (Fig. 2 E). Indeed, events in G6 stained
positively for the transcription factor T-bet (Fig. 2 F). Similar
results were obtained with a modified lineage cocktail in which
anti-F4/80 antibodies were added but anti-B220 antibodies were
excluded (Fig. 2, G–I), used to replicate the lineage markers
previously used to identify ILCregs (Wang et al., 2017). These data
show that G6 events were T-bet–expressing, lineage-positive
cells, inconsistent with the reported phenotype of ILCregs.
Intestinal inflammation resulting from DSS-induced injury
and infection with C. rodentium was previously reported to increase frequencies of ILCregs in the small intestine (Wang et al.,
2017). To test whether intestinal inflammation would give rise to
a population of IL-10–producing ILCs in our laboratory, mice
were treated with 3% DSS in drinking water. On day 8, eGFP was
absent in Lin−CD45+CD127+ cells in small intestine lamina propria but was expressed by CD4+ T cells (Fig. 3, A–C). Disease was
confirmed at this time point by body weight loss (Fig. 3 D).
Mirroring observations in naive mice, >99% of Lin−CD45+CD127+
cells in small intestine lamina propria of DSS-treated mice were
ILC2s or ILC3s; there was no increase in an ILC population distinct from ILC1s, ILC2s, or ILC3s (Fig. 3 E). Similarly, there was
no increase in an innate lymphoid population lacking ILC1, ILC2,
and ILC3 markers on day 8 of infection with the enteric pathogenic bacterium C. rodentium (Fig. 3 F). Taken together, these
data show that ILCregs are not generalizable across mice.

Secreted IL-10 activates IL-10 production through a positive
feedback loop
Our results suggested that IL-10 secreted by ILC2s might activate
a feedback loop that amplified IL-10 production. To determine
Journal of Experimental Medicine
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Figure 3. No evidence for ILCreg induction during intestinal inflammation. (A and B) Representative flow cytometry plots showing IL-10–eGFP expression in Lin−CD45+CD127+ cells (A) and CD4+ T cells (B) on day 8 of DSS treatment. (C) Frequencies of Lin−CD45+CD127+ cells and CD4+ T cells expressing
eGFP in small intestine lamina propria in multiple mice (n = 8). (D) Body weight loss as a percentage of initial weight at day 8 of DSS treatment (n = 6). D0, day
0; D8, day 8. (E and F) Frequencies of Lin−CD45+CD127+ cells that lacked markers for both ILC2s and ILC3s in small intestine lamina propria of mice treated
with DSS in drinking water for 8 d (n = 5; E) or in mice infected for 8 d with C. rodentium (n = 5; F). Frequencies of ILC2s and ILC3s are shown as controls. Bars
indicate means ± SD. Data were pooled from two independent experiments (C) or are representative of two independent experiments (D–F).

the impact of secreted IL-10 in vitro, cultures containing ILC2s
and positive regulators of IL-10 were treated with IL10–blocking antibodies. eGFP expression in ILC2s was blunted
by IL-10 inhibition, indicating that ILC2s can act to amplify IL10 signals (Fig. 4 H). This result also provided functional validation that IL-10 protein was secreted by ILC2s. Since IL-2 and
IL-4, the strongest elicitors of IL-10 in the screen, are molecules
that can be secreted by ILC2s, we tested whether one of these
cytokines might induce the other to activate IL-10 production
(Moro et al., 2010). The use of blocking antibodies revealed that
the activation of IL-10 production by IL-4 did not require IL-2,
and likewise, the induction of IL-10 by IL-2 did not require IL-4
(Fig. 4 I). Thus, IL-2 and IL-4 can induce IL-10 in ILC2s independently of one another.
In this study, we showed that the ILCreg, a recently described
Thy1+CD127+ IL-10–producing ILC, is not a generalizable immune population across mice. Support for this conclusion was
provided by multiple experiments. First, using the same reporter mouse that was used to originally identify this population, we found no evidence for ILCregs based on IL-10 (eGFP)
expression in naive mice (Wang et al., 2017). These results were
not due to overly stringent lineage- or FSC/SSC-gating, since
relaxing these parameters did not enable ILCreg detection.
Second, while ILCregs were previously reported to be ∼13% of
lineage-negative cells in small intestine lamina propria based
on function marking alone (Wang et al., 2017), we found that
>99% of lineage-negative, CD45+CD127+ lymphocytes were either ILC2s or ILC3s (ILC1s being excluded by lineage gating)
in mice bred at WUSM. Further examination of the <1% of
Lin−CD45+CD127+ cells that lacked ILC2 and ILC3 markers
Bando et al.
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showed that they exhibited a high geometric mean fluorescence
intensity (gMFI) in the lineage dump channel and expressed
T-bet, indicating that these rare events were lineage-positive
cells that had been inadequately excluded. These data indicate
that the absence of ILCregs could not be explained by insufficient eGFP fluorescence detection or reduced IL-10 production
caused by environmental factors such as diet or microbiota,
since regardless of eGFP production, ILCregs were absent in the
small intestine. Third, analyses of C57BL/6 mice purchased from
JAX, Taconic Biosciences, and Charles River Laboratories indicated that ILCregs were absent from mice from multiple facilities. Use of C57BL/6J and C57BL/6N mice showed that ILCreg
detection was not caused by genetic differences between C57BL/6
substrains. Finally, there was no observed expansion of an ILC
distinct from ILC1s, ILC2s, and ILC3s during two models of gut
inflammation (DSS colitis and C. rodentium infection) previously
reported to increase ILCreg numbers, negating a generalizable role
for ILCregs under these conditions (Wang et al., 2017). Taken together, these data show that ILCregs are not universally present
in mice.
The possibility remains that specific microbiota may be required for the development of ILCregs. Such a strict requirement
would indicate that ILCregs are unlike other ILCs, which are
ubiquitously present in C57BL/6 mice across animal facilities.
In one of the first reports that identified ILC2s, sorted splenic
ILC2s were shown to secrete IL-10 (Neill et al., 2010). More
recently, IL-10 was shown to be produced by lung ILC2s in response to treatment with papain (Miyamoto et al., 2019; Seehus
et al., 2017). In our study, we showed that a modest percentage
of ILC2s produced IL-10 in the naive mouse small intestine.
Journal of Experimental Medicine
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Figure 4. IL-10 production by intestinal ILC2s is induced by IL-2, IL-4, IL-10, IL-27, and NMU, and suppressed by TL1A. (A) Representative flow cytometry plots showing IL-25R, KLRG1, and GATA3 staining in Lin−CD45+CD127+Thy1− cells. (B) Representative flow cytometry plots showing expression of
eGFP in Lin−CD45+CD127+KLRG1+ ILC2s that are Thy1+ and Thy1−. (C) Heatmap depicting frequencies of eGFP+ cells obtained by flow cytometric analysis of
ILC2s cultured 2 d with IL-33, IL-25, and either IL-7 or TSLP, in combination with the indicated molecules. (D and E) Validation of results in C. Cells were
cultured for 3 d with IL-33, IL-25, IL-7, and the indicated conditions (n = 5–6). (F) ILC2s cultured as in C using pre-activated ILC2s. (G) IL-4- or IL-2-elicited eGFP
expression in ILC2s treated with TL1A (n = 4). (H and I) Isolated ILC2s were treated with IL-25, IL-33, IL-7, and the indicated molecules in the presence or
absence of IL-10–blocking antibodies (n = 5–6; H) or in the presence or absence of IL-2- and IL-4–blocking antibodies (n = 3; I). Bars indicate means ± SD. Data
from D, E, and H were analyzed from the same experiments. Data were pooled from two independent experiments (E and H) or are representative of two
independent experiments (A, B, G, and I). *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
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Materials and methods
Animals
B6.129S6-Il10tm1Flv/J (IL-10–eGFP) mice backcrossed to C57BL/6
for over 10 generations were purchased from JAX (#008379;
Kamanaka et al., 2006). IL-10–eGFP mice were then crossed to
C57BL/6J mice purchased from JAX (#00064). C57BL/6N mice
were purchased from Taconic Biosciences (#B6NTac) and
Charles River Laboratories (#027). Mice were used for experiments at 6–14 wk of age. Both sexes were used, with the
exception of the mouse vendor comparison experiments, in
which male mice were purchased. Mice in vendor comparison
experiments were euthanized within 48 h of arriving at our
animal facility. All animals were housed in specific pathogenfree facilities at WUSM in St. Louis, and studies were conducted
in accordance with the Washington University Animal Studies
Committee.
Cell isolation
Single-cell suspensions of intestinal lamina propria were generated as previously described (Bando et al., 2018). Peyer’s
patches were removed from small intestines. Large intestines
consisted of both cecum and colon combined. Intestines were
cleaned and opened lengthwise and then agitated for 20 min in
HBSS (Gibco) that contained EDTA (Corning), bovine calf serum
(Atlanta Biologics), and Hepes (Corning). Tissues were vortexed,
Bando et al.
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and then agitated for an additional 20 min in fresh HBSS buffer
that contained EDTA, bovine calf serum, and Hepes, followed by
vortexing. Intestines were then rinsed with HBSS supplemented
with Hepes to remove traces of EDTA, and then digested with
collagenase IV (Sigma) in complete RPMI under agitation for
40 min for small intestines or 1 h for large intestines. Complete
RPMI contained RPMI from Sigma enriched with 10% bovine
calf serum, L-alanyl-L-glutamine dipeptide (Gibco), nonessential amino acids (Corning), Hepes, kanamycin sulfate (Gibco),
sodium pyruvate (Corning), and β-mercaptoethanol (Sigma).
Digests were filtered through 100-micron nylon mesh and
subjected to density gradient centrifugation using Percoll (GE
Healthcare).
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Production of IL-10 in intestinal ILC2s was enhanced by IL-2,
IL-4, IL-10, IL-27, and NMU, and suppressed by the TNF superfamily member TL1A. Several of the molecules found to impact IL-10 production in ILC2s have also been shown to affect IL10 production in T cells, creating additional parallels between
the two cell types (Bando and Colonna, 2016; Saraiva and
O’Garra, 2010). Our finding that secreted IL-10 induced additional IL-10 production indicates that a positive feedback loop in
ILC2s may rapidly suppress effector cell cytokine production via
IL-10. Together, data generated from these experiments suggest
that the production of IL-10 by ILC2s in vivo is tuned by the cytokine milieu, which is likely dependent on tissue microenvironment.
We feel that it is unlikely that the Lin−CD127+eGFP+ population previously identified as ILCregs was comprised of misidentified ILC2s based on reported differences between these
two populations: (1) ILCregs expressed low or no GATA3 and
KLRG1, while both markers are highly expressed in ILC2s; (2)
ILCregs lacked lineage tracing with PLZF, which labels ILC2s
due to expression of this gene in a common ILC precursor
(Constantinides et al., 2014); and (3) IL-10 production in ILCregs
was previously reported to be induced by TGF-β, while IL-10
production in ILC2s has been shown to be suppressed by this
cytokine (Seehus et al., 2017). In addition, the types of inflammatory conditions that were previously reported to expand ILCregs would not be expected to activate ILC2s.
The physiological relevance of ILC2-derived IL-10 in the intestine remains an area for future investigation. Unique functions of IL-10 secreted by intestinal ILC2s will require further
work to determine when these cells produce IL-10 in vivo, and to
identify the specific cell types impacted by ILC2-derived IL-10.

Flow cytometry
Cells were incubated with Fragment, crystallizable (Fc) block for
15–20 min, and then stained with primary antibodies (Table S1)
for 20–30 min in buffer that contained Fc block. Stains with
fluorescently labeled streptavidin were incubated for 20 min.
Live cells were stained using a Live/Dead Fixable Cell Stain
Kit (Thermo Fisher Scientific) or DAPI (Sigma). Intracellular
staining was conducted using the eBioscience Transcription
Factor staining kit. Cells were run on a FACSCantoII (BD Biosciences) and analyzed using FlowJo (FlowJo LLC). Lineage
cocktails included antibodies to CD3e, CD4, CD5, CD8a, CD19,
CD11b, CD11c, Gr-1, NK1.1, Ter119, and B220. “Modified” lineage
cocktails included antibodies to CD3e, CD4, CD5, CD8a, CD19,
CD11b, CD11c, Gr-1, NK1.1, Ter119, and F4/80.
Intestinal inflammation models
Mice were infected with 2 × 109 C. rodentium (strain DBS100;
ATCC) via oral gavage. For DSS colitis studies, mice were provided 3% DSS (#160110; MP Biomedicals) in drinking water.
Cell culture
ILC2s and ILC3s were purified from small intestine lamina
propria with an Aria II (BD Biosciences). 12 × 103 ILC2s were
cultured in complete RPMI with 10 ng/ml IL-33 and IL-25 in the
presence of IL-7 or TSLP (50 ng/ml) for 2 d (screens) or 3 d
(validation studies) with candidate molecules (Table S2). 50 ×
103 ILC3s were cultured with 10 ng/ml IL-1β and IL-23 in the
presence of IL-7 for 2 d. For screens, cells were treated with
10 ng/ml of candidate molecules, except for IL-27, VIP, leptin,
and NMU (50 ng/ml); 2,3,7,8-Tetrachlorodibenzodioxin (31 nM);
and vitamin D3 (100 nM). Blocking antibodies to IL-2, IL-4, and
IL-10 were purchased from BioXCell and were used at a concentration of 15 μg/ml. To generate pre-activated ILC2s, sorted
ILC2s were cultured for 7 d with IL-25, IL-33, and IL-7 before
being resorted for eGFP-negative cells.
Statistical analysis
Paired and unpaired student’s t tests and one-way ANOVA were
conducted using Prism software.
Online supplemental material
Fig. S1 shows IL-10–eGFP expression in intestinal NK cells, ILC1s,
and ILC3s. Table S1 lists catalog numbers for antibodies used for
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flow cytometry. Table S2 lists catalog numbers for soluble mediators used in screens.
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Figure S1. IL-10 production in NK cells, ILC1s, and ILC3s. (A) Expression of IL-10–eGFP in NK1.1+ cells (pooled ILC1s and NK cells) and ILC3s isolated from
naive small intestine lamina propria. (B) Screen for IL-10 elicitors using sorted small intestine ILC3s cultured for 2 d with IL-23, IL-1β, IL-7, and a candidate
mediator. (C) Expression of IL-10–eGFP in small intestine lamina propria ILC3s sorted from biological replicates and cultured for 2 d with IL-23, IL-1β, IL-7, and
molecules that were found to induce IL-10 in ILC2s (n = 4). (D) Expression of IL-10–eGFP in NK1.1+ cells (pooled ILC1s and NK cells), ILC3s, and CD4+ T cells
isolated from small intestine lamina propria of mice 4 d after inoculation with 108 CFU of C. difficile VPI 10463 (n = 3). Bars indicate means ± SD. Data from A, C,
and D are representative of two independent experiments.
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Table S1. Antibodies and secondary reagents
Antibody or secondary reagent

Catalog number

Company

Anti-CD3e PerCP-cy5.5

100328

BioLegend

Anti-CD4 PerCP-cy5.5

100434

BioLegend

Anti-CD5 PerCP-cy5.5

100624

BioLegend

Anti-CD8a PerCP-cy5.5

100734

BioLegend

115534

BioLegend

Anti-CD11b PerCP-cy5.5

101228

BioLegend

Anti-CD11c PerCP-cy5.5

45-0114-82

eBioscience

Anti-Gr-1 PerCP-cy5.5

108428

BioLegend

Anti-NK1.1 PerCP-cy5.5

108728

BioLegend

Anti-Ter119 PerCP-cy5.5

116228

BioLegend

Anti-B220 PerCP-cy5.5

103236

BioLegend

Anti-CD45 APC/cy7

103116

BioLegend

Anti-CD127 biotin

135006

BioLegend

Anti-CD90.2 APC

105312

BioLegend

Anti-CD4 APC

17-0041-83

eBioscience

Anti-CD11c PE-cy7

117318

BioLegend

Anti-CD11b APC/cy7

101226

BioLegend

Anti-B220 Pacific Blue

103227

BioLegend

Anti-CD3e BV421

562600

BD Biosciences

Anti-GATA3 AF488

560163

BD Biosciences

Anti-RORgt PE

12-6988-82

eBioscience

Anti-F4/80 PerCP-cy5.5

123128

BioLegend

Anti-T-bet BV421

563318

BD Biosciences

Anti-IL-25R PE

12-7361-80

eBioscience

Anti-KLRG1 APC

138412

BioLegend

Anti-NKp46 biotin

137616

BioLegend

Anti-NK1.1 PE-cy7

108714

BioLegend

SA-PE-cy7

25-4317-82

eBioscience

SA-BV421

563259

BD Biosciences
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Anti-CD19 PerCP-cy5.5

Journal of Experimental Medicine
https://doi.org/10.1084/jem.20191520

S2

Table S2. Soluble mediators
Molecule

Catalog number

Company

Mouse IL-25

1399-IL

R&D

Mouse IL-33

210-33

Peprotech

Mouse TSLP

555-TS

R&D

Mouse IL-2

402-ML

R&D

Mouse IL-10

210-10

Peprotech

Mouse IL-27

577402

BioLegend

214-14

Peprotech

Mouse IFNγ

315-05

Peprotech

VIP

1911

Tocris

Mouse IFNβ

12400-1

PBL Assay Science

Mouse IL-6

406-ML

R&D

Mouse IL-18

767002

BioLegend

Mouse TL1A

1896-TL/CF

R&D

TNFα

315-01A

Peprotech

Human LIF

300-05

Peprotech

Mouse IL-12 p70

210-12

Peprotech

Mouse IL-21

210-21

Peprotech

Human TGF-β1

100-21

Peprotech

Human IFN-λ2

300-02K

Peprotech

2,3,7,8-TCDD

48599

Supelco

1α,25-Dihydroxyvitamin D3

D1530

Sigma

Human leptin

300-27

Peprotech

Human NMU-25

17617

Cayman Chemical

Mouse IL-1β

401-ML

R&D

Mouse IL-23

1887-ML

R&D
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Mouse IL-4

S3

